Otonomy to Participate in Four Upcoming Investor Conferences
September 02 2020 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that management is scheduled to
participate in four upcoming virtual investor conferences.
- Citi’s 15th Annual BioPharma Virtual Conference on September
9-10, 2020: 1 on 1 investor meetings.
- H.C. Wainwright 22nd Annual Global Investment Conference:
presentation on September 14, 2020 at 12 p.m. ET (9 a.m.
PT).
- Cantor Virtual Global Healthcare Conference: presentation on
September 16, 2020 at 9:20 a.m. ET (6:20 a.m. PT).
- Oppenheimer Fall Healthcare Life Sciences & MedTech Summit:
presentation on September 23, 2020 at 10 a.m. ET (7 a.m. PT).
A live audio webcast of the presentations will be available
through the Events page of the company's website
(www.otonomy.com).
About Otonomy
Otonomy is a biopharmaceutical company dedicated to the
development of innovative therapeutics for neurotology. The company
pioneered the application of drug delivery technology to the ear in
order to develop products that achieve sustained drug exposure from
a single local administration. This approach is covered by a broad
patent estate and is being utilized to develop a pipeline of
products addressing important unmet medical needs including
Ménière’s disease, hearing loss, and tinnitus. For additional
information please visit www.otonomy.com.
Contacts:
Media Inquiries:Spectrum ScienceChloé-Anne RamseyVice
President404.865.3601 cramsey@spectrumscience.com
Investor Inquiries:Westwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024